Article Text
PDF
Statistics from Altmetric.com
Q In patients with type 2 diabetes mellitus, does inhaled insulin added onto or replacing a failing regimen with 2 oral agents reduce haemoglobin A1c (HbA1c) concentrations?
Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Internal medicine ★★★★★★★ Endocrine ★★★★★☆☆
METHODS
Design:
randomised controlled trial.
Allocation:
concealed.*
Blinding:
unblinded.*
Follow up period:
12 weeks.
Setting:
48 outpatient centres in the US and Canada.
Patients:
309 patients 35–80 years of age (mean age 57 y, 65% men) with ⩾1 year history of type 2 diabetes treated with a stable oral agent regimen (1 insulin secretagogue and 1 insulin sensitiser) and HbA1c of 8–11%. Exclusion criteria included predisposition to severe hypoglycaemia; hospital admission or emergency department visit for poor diabetic control in previous 6 months; …
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- Glossary